Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Fort Worth, Texas 76134


The purpose of this study is to compare SYSTANE® HYDRATION to Hyabak 0.15% based on total ocular surface staining scores (TOSS) at Day 42.

Study summary:

Subjects will first be dispensed preservative-free 0.9% saline eye drops (saline eye drops) to be used during the Run-in phase between Screening Visit and Day 0 (Visit 1). Subjects who qualify will be randomized in a 1:1 manner to receive either treatment with SYSTANE® HYDRATION Lubricant Eye Drops or Hyabak 0.15% Eye Drops.


Inclusion Criteria: - Willing and able to attend all study visits; - Use of non-BAK (Benzalkonium Chloride) artificial tears at least once a day, for at least 3 months prior to Screening Visit; - Diagnosis of Dry Eye (by a health care professional) for at least 3 months prior to Screening Visit; - Other protocol-defined inclusion criteria may apply. Exclusion Criteria: - Women of childbearing potential who are pregnant or breast feeding; - Any hypersensitivity to the use of the study product formulations or an allergy to any ingredient(s) contained within product formulations; - Ocular abnormalities in either eye that could adversely affect the safety or efficacy outcome; - Active ocular infection (bacterial, viral, or fungal) or active inflammation not associated with dry eye; - Use of chronic systemic medications: (prescription, over the counter, vitamins/supplements) on a stable dose for less than 30 days prior to Screening Visit, or any anticipated change in dosing regimen during the course of the study; - History of ocular or intraocular surgery or serious ocular trauma in either eye within the past 6 months prior to Screening Visit; - Any medical condition (systemic or ophthalmic) that may, in the opinion of the Investigator, preclude the safe administration of test article or safe participation in the study; - Use of any topical ocular over-the-counter or prescribed medications in either eye (with the exception of artificial tears/gels/ lubricants) 2 weeks prior to Screening Visit; - Contact lens use within 2 weeks prior to Screening Visit and unwilling to avoid contact lens use during the course of the study; - Unwilling to avoid use of additional artificial tears (other than study medication) throughout the study; - Other protocol-defined exclusion criteria may apply.



Primary Contact:

Study Director
Senior Clinical Manager, GCRA
Alcon Research

Backup Contact:


Location Contact:

Fort Worth, Texas 76134
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.